Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats
The higher maintenance dose used with Wegovy allows for stronger weight-loss effects compared with the doses commonly used for diabetes management
For example, a 2024 review found that pyruvate promoted weight loss in some studies, but produced inconsistent results overall
Whats interesting then is we know that it would suppress our own production
[4] [5] However, there is no established association between semaglutide and acquired hypothyroidism or clinically significant thyroid dysfunction affecting metabolism in humans
[DOI] [PubMed] [Google Scholar] 114.Lambrecht B.N., Germonpr P.R., Everaert E.G., Carro-Muino I., De Veerman M., de Felipe C., Hunt S.P., Thielemans K., Joos G.F., Pauwels R.A